stars 1 stars 2 stars 3

ExPharma Limited is an company focussed on R&D and investment. We are a small but agile and highly focused team of senior individuals, with established networks and track records of entrepreneurial and investment success. We thrive on challenge and continually seek inventive solutions for both our own and clients projects. Our expertise and experience within R&D, CMC, regulatory affairs and business transactions ensures success and makes us the ideal partner to bring your concept to market. Spanning a range of sectors within health and wellness, our activities cover food supplements, foods for special medical purposes, medical devices and diagnostics and our networks extend to pharmaceutical and nutrition companies, universities and investors.

ExPharma Limited Questions

The ExPharma Limited annual revenue was $3 million in 2026.

Paolo Rampazzo is the Director of ExPharma Limited.

1 people are employed at ExPharma Limited.

The NAICS codes for ExPharma Limited are [325, 3254, 32, 32541].

The SIC codes for ExPharma Limited are [283, 28].

Top ExPharma Limited Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users